Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.330
-0.120 (-2.70%)
At close: Jul 24, 2026, 4:00 PM EDT
4.340
+0.010 (0.23%)
Pre-market: Jul 27, 2026, 5:44 AM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $308.24 million as of July 27, 2026. Its market cap has increased by 183.70% in one year.
Market Cap
308.24M
Enterprise Value
135.13M
1-Year Change
183.70%
Ranking
Category
Stock Price
$4.33
ChartMarket Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $308.24M, a decrease of -47.53%. That is a compound annual growth rate of -9.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 308.24M | 252.62% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 338.48M |
| Vicore Pharma Holding AB | 325.67M |
| Vanda Pharmaceuticals | 311.50M |
| Lyell Immunopharma | 309.49M |
| Indaptus Therapeutics | 295.56M |
| OmniAb | 294.29M |
| Foghorn Therapeutics | 284.76M |
| Fate Therapeutics | 280.91M |